Newsroom
Sorted by: Latest
-
Socure RiskOS® Platform Integrates Prism Data to Transform Credit Risk Underwriting
INCLINE VILLAGE, Nev.--(BUSINESS WIRE)--Socure, the leading trust infrastructure for global identity and risk intelligence, and Prism Data, a top cash-flow underwriting analytics company, today announced a strategic partnership to bring market-leading cash flow analytics directly into Socure RiskOS®, Socure’s unified fraud, compliance, and risk decisioning platform. By embedding Prism’s CashScore® and intelligence suite into the Socure RiskOS ecosystem, the partnership enables lenders to move b...
-
Unio Health Partners and Thesis Care Announce Partnership to Scale AI-Powered Clinical Teams Across Specialty Care
NEW YORK & TORRANCE, Calif.--(BUSINESS WIRE)--Thesis Care and Unio Health Partners partner to deploy AI care team agents across Unio's California specialty practices serving 500,000+ patients....
-
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events
WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research...
-
Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation, today announced the appointment of David P. Kerstein, M.D., as chief medical officer. Dr. Kerstein brings significant experience in oncology drug development across early- and late-stage precision oncology programs. “David is an accomplished phy...
-
BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing
NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced it has secured initial commitments for $4.1M of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5.0M (the "Financing"). Proceeds from the Financing will be used to bolster the Company’s digital asset treasury and will provide working capital in support of a comprehensive strategic review. With the anticipated proceeds, the Company exp...
-
AMC Theatres® and ODEON Cinemas Welcome More Than 5 Million Moviegoers Globally Over Memorial Day Weekend — AMC Records Its Best Thursday-Through-Monday U.S. Attendance in 2026
LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Entertainment (NYSE: AMC), the largest theatrical exhibitor in the United States and in the world, welcomed more than 5.0 million moviegoers to its theatres across the United States and to its ODEON Cinemas locations internationally during the U.S. Memorial Day holiday weekend, spanning Thursday through Monday. At its U.S. locations, AMC enjoyed its highest-attended Thursday-through-Monday period of 2026, reflecting continued strong momentum at the box office...
-
Prilenia Donates Clinical Trial Datasets to CHDI Foundation to Advance Huntington's Disease Research
NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V. today announced a Data Use Agreement (DUA) under which Prilenia will provide CHDI with clinical data from the placebo arms of its PRIDE and PROOF studies for the purpose of advancing research into treatments for Huntington's disease (HD). “Collaboration which balances scientific rigor with data openness is an ethical and scientific imperative. Sharing data is key to accelerating and advancing knowledge and un...
-
Fastly to Present at Upcoming Investor Conference
SAN FRANCISCO--(BUSINESS WIRE)--Fastly, Inc. (NASDAQ: FSLY), a leader in global edge platforms, today announced that management will be participating in a presentation at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2nd at 5:40 p.m. ET. A webcast of the presentation will be available on Fastly’s Investor Relations website at https://investors.fastly.com. About Fastly, Inc. Fastly’s powerful and programmable edge cloud platform helps the world’s top brands deliver onl...
-
Pagaya Closes AAA-Rated Upsized $600 Million RPM 2026-3 Auto ABS Transaction
NEW YORK--(BUSINESS WIRE)--Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or the “Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced the closing of RPM 2026-3, a $600 million upsized auto asset-backed securitization (ABS). This marks Pagaya’s third fully pre-funded auto ABS transaction of 2026 and its largest to date, bringing the total amount of pre-funded auto ABS raised this year to $1.5 billion. “We are encouraged by...
-
Melanie McFaddin with Wiley Bros. – Aintree Capital &Partners Represents CC Pace Systems, Inc. in its acquisition by Mitchell Martin, Inc.
NASHVILLE, Tenn.--(BUSINESS WIRE)--Melanie McFaddin, Representative of Wiley Bros. – Aintree Capital &Partners is pleased to announce its representation of CC Pace Systems, Inc. (“CC Pace” and the “Company”) in its sale to Mitchell Martin, Inc. (“MMI”), an employee-owned IT, healthcare, and professional staffing firm. The acquisition expands MMI’s footprint in the mid-Atlantic and mid-West regions and deepens its capabilities in financial services IT staffing, an area of sustained and growi...